ANZ Breast Cancer Trials Group Limited

Australia

1 March 2019 - 29 February 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for ANZ Breast Cancer Trials Group Limited published between 1 March 2019 - 29 February 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0

Top articles by Altmetric score in current window

Article has an altmetric score of 43

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Nature Communications

2019-04-15

1 March 2019 - 29 February 2020

International vs. domestic collaboration by Share

  • 9.76% Domestic
  • 90.24% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (32 total)

  • ANZ Breast Cancer Trials Group Limited, Australia
  • Domestic institution
  1. QIMR Berghofer Medical Research Institute, Australia (0.02)
    0
    0.02
  2. The University of Melbourne (UniMelb), Australia (0.02)
    0
    0.02
  3. The University of Sydney (USYD), Australia (0.01)
    0
    0.01
  4. Westmead Hospital (WSLHD), Australia (0.01)
    0
    0.01
  5. Australian National University (ANU), Australia (0.01)
    0
    0.01
  6. St Vincent's Health Australia, Australia (0.01)
    0
    0
  7. Monash University, Australia (0)
    0
    0
  8. The University of Western Australia (UWA), Australia (0)
    0
    0
  9. The University of Queensland (UQ), Australia (0)
    0
    0
  10. Western Sydney University, Australia (0)
    0
    0

Top 10 international collaborators by Share (225 total)

  • ANZ Breast Cancer Trials Group Limited, Australia
  • Foreign institution
  1. University of Cambridge, United Kingdom (UK) (0.05)
    0
    0.05
  2. Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK) (0.05)
    0
    0.05
  3. Helmholtz Association of German Research Centres, Germany (0.03)
    0
    0.03
  4. Netherlands Cancer Institute (NKI), Netherlands (0.03)
    0
    0.03
  5. Karolinska Institute (KI), Sweden (0.02)
    0
    0.02
  6. University of Cologne (UoC), Germany (0.02)
    0
    0.02
  7. Erasmus University Rotterdam (EUR), Netherlands (0.02)
    0
    0.02
  8. Hannover Medical School (MHH), Germany (0.02)
    0
    0.02
  9. Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy (0.02)
    0
    0.02
  10. The Institute of Cancer Research (ICR), United Kingdom (UK) (0.02)
    0
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

ANZ Breast Cancer Trials Group Limited
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER